Crossmark

Clinical Role of Programmed Cell Death-1 Expression in Patients with Non-muscle-invasive Bladder Cancer Recurring After Initial Bacillus Calmette–Guérin Therapy

Crossref DOI link: https://doi.org/10.1245/s10434-018-6498-2

Published Online: 2018-05-01

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fukumoto, Keishiro

Kikuchi, Eiji

Mikami, Shuji

Hayakawa, Nozomi

Matsumoto, Kazuhiro

Niwa, Naoya

Oya, Mototsugu
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science Grants-in-Aid for Young Scientists (15K20107)
License Information

Text and Data Mining valid from 2018-05-01
More Information

Article History

Received: 18 October 2017

First Online: 1 May 2018

Document is current

Any future updates will be listed below